REIT - Healthcare Facilities
Compare Stocks
2 / 10Stock Comparison
HR vs DOC
Revenue, margins, valuation, and 5-year total return — side by side.
REIT - Healthcare Facilities
HR vs DOC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | ||
|---|---|---|
| Industry | REIT - Healthcare Facilities | REIT - Healthcare Facilities |
| Market Cap | $6.95B | $11.48B |
| Revenue (TTM) | $1.15B | $2.87B |
| Net Income (TTM) | $-201M | $222M |
| Gross Margin | -9.7% | 21.2% |
| Operating Margin | 19.5% | 14.4% |
| Forward P/E | — | 84.8x |
| Total Debt | $4.15B | $10.44B |
| Cash & Equiv. | $26M | $538M |
HR vs DOC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Healthcare Realty T… (HR) | 100 | 64.9 | -35.1% |
| Healthpeak Properti… (DOC) | 100 | 67.0 | -33.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: HR vs DOC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
HR is the clearest fit if your priority is long-term compounding and sleep-well-at-night.
- 42.2% 10Y total return vs DOC's 9.2%
- Lower volatility, beta 0.13, Low D/E 88.7%, current ratio 1.75x
- Beta 0.13, yield 5.6%, current ratio 1.75x
DOC carries the broadest edge in this set and is the clearest fit for income & stability and growth exposure.
- Dividend streak 1 yrs, beta 0.52, yield 7.4%
- Rev growth 4.5%, EPS growth -72.2%, 3Y rev CAGR 11.0%
- 4.5% FFO/revenue growth vs HR's -6.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 4.5% FFO/revenue growth vs HR's -6.9% | |
| Value | Better valuation composite | |
| Quality / Margins | 7.7% margin vs HR's -17.5% | |
| Stability / Safety | Beta 0.13 vs DOC's 0.52, lower leverage | |
| Dividends | 7.4% yield, 1-year raise streak, vs HR's 5.6% | |
| Momentum (1Y) | +39.1% vs DOC's +0.9% | |
| Efficiency (ROA) | 1.1% ROA vs HR's -2.1%, ROIC 2.3% vs 0.7% |
HR vs DOC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
HR vs DOC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
DOC leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
DOC is the larger business by revenue, generating $2.9B annually — 2.5x HR's $1.1B. DOC is the more profitable business, keeping 7.7% of every revenue dollar as net income compared to HR's -17.5%. On growth, DOC holds the edge at +7.1% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | ||
|---|---|---|
| RevenueTrailing 12 months | $1.1B | $2.9B |
| EBITDAEarnings before interest/tax | $767M | $1.5B |
| Net IncomeAfter-tax profit | -$201M | $222M |
| Free Cash FlowCash after capex | $201M | $893M |
| Gross MarginGross profit ÷ Revenue | -9.7% | +21.2% |
| Operating MarginEBIT ÷ Revenue | +19.5% | +14.4% |
| Net MarginNet income ÷ Revenue | -17.5% | +7.7% |
| FCF MarginFCF ÷ Revenue | +17.5% | +31.1% |
| Rev. Growth (YoY)Latest quarter vs prior year | -10.5% | +7.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +99.8% | +3.6% |
Valuation Metrics
DOC leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, DOC's 13.3x EV/EBITDA is more attractive than HR's 16.8x.
| Metric | ||
|---|---|---|
| Market CapShares × price | $6.9B | $11.5B |
| Enterprise ValueMkt cap + debt − cash | $11.1B | $21.4B |
| Trailing P/EPrice ÷ TTM EPS | -28.06x | 165.10x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 84.75x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 16.80x | 13.34x |
| Price / SalesMarket cap ÷ Revenue | 5.89x | 4.07x |
| Price / BookPrice ÷ Book value/share | 1.49x | 1.38x |
| Price / FCFMarket cap ÷ FCF | 54.74x | 10.01x |
Profitability & Efficiency
DOC leads this category, winning 5 of 9 comparable metrics.
Profitability & Efficiency
DOC delivers a 2.6% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $-4 for HR. HR carries lower financial leverage with a 0.89x debt-to-equity ratio, signaling a more conservative balance sheet compared to DOC's 1.26x. On the Piotroski fundamental quality scale (0–9), HR scores 7/9 vs DOC's 4/9, reflecting strong financial health.
| Metric | ||
|---|---|---|
| ROE (TTM)Return on equity | -4.3% | +2.6% |
| ROA (TTM)Return on assets | -2.1% | +1.1% |
| ROICReturn on invested capital | +0.7% | +2.3% |
| ROCEReturn on capital employed | +1.0% | +2.8% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 4 |
| Debt / EquityFinancial leverage | 0.89x | 1.26x |
| Net DebtTotal debt minus cash | $4.1B | $9.9B |
| Cash & Equiv.Liquid assets | $26M | $538M |
| Total DebtShort + long-term debt | $4.1B | $10.4B |
| Interest CoverageEBIT ÷ Interest expense | -0.21x | 1.78x |
Total Returns (Dividends Reinvested)
HR leads this category, winning 6 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in HR five years ago would be worth $10,343 today (with dividends reinvested), compared to $7,606 for DOC. Over the past 12 months, HR leads with a +39.1% total return vs DOC's +0.9%. The 3-year compound annual growth rate (CAGR) favors HR at 5.2% vs DOC's -0.9% — a key indicator of consistent wealth creation.
| Metric | ||
|---|---|---|
| YTD ReturnYear-to-date | +18.9% | +4.4% |
| 1-Year ReturnPast 12 months | +39.1% | +0.9% |
| 3-Year ReturnCumulative with dividends | +16.4% | -2.6% |
| 5-Year ReturnCumulative with dividends | +3.4% | -23.9% |
| 10-Year ReturnCumulative with dividends | +42.2% | +9.2% |
| CAGR (3Y)Annualised 3-year return | +5.2% | -0.9% |
Risk & Volatility
HR leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
HR is the less volatile stock with a 0.13 beta — it tends to amplify market swings less than DOC's 0.52 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HR currently trades 99.5% from its 52-week high vs DOC's 83.9% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | ||
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.13x | 0.52x |
| 52-Week HighHighest price in past year | $20.03 | $19.68 |
| 52-Week LowLowest price in past year | $14.09 | $15.70 |
| % of 52W HighCurrent price vs 52-week peak | +99.5% | +83.9% |
| RSI (14)Momentum oscillator 0–100 | 72.2 | 43.7 |
| Avg Volume (50D)Average daily shares traded | 3.4M | 7.6M |
Analyst Outlook
DOC leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Wall Street rates HR as "Hold" and DOC as "Buy". Consensus price targets imply 8.2% upside for DOC (target: $18) vs -3.0% for HR (target: $19). For income investors, DOC offers the higher dividend yield at 7.39% vs HR's 5.55%.
| Metric | ||
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Hold | Buy |
| Price TargetConsensus 12-month target | $19.33 | $17.86 |
| # AnalystsCovering analysts | 29 | 40 |
| Dividend YieldAnnual dividend ÷ price | +5.6% | +7.4% |
| Dividend StreakConsecutive years of raises | 0 | 1 |
| Dividend / ShareAnnual DPS | $1.11 | $1.22 |
| Buyback YieldShare repurchases ÷ mkt cap | +0.1% | +0.8% |
DOC leads in 4 of 6 categories (Income & Cash Flow, Valuation Metrics). HR leads in 2 (Total Returns, Risk & Volatility).
HR vs DOC: Frequently Asked Questions
9 questions · data-driven answers · updated daily
01Is HR or DOC a better buy right now?
For growth investors, Healthpeak Properties, Inc.
(DOC) is the stronger pick with 4. 5% revenue growth year-over-year, versus -6. 9% for Healthcare Realty Trust Incorporated (HR). Healthpeak Properties, Inc. (DOC) offers the better valuation at 165. 1x trailing P/E (84. 8x forward), making it the more compelling value choice. Analysts rate Healthpeak Properties, Inc. (DOC) a "Buy" — based on 40 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which is the better long-term investment — HR or DOC?
Over the past 5 years, Healthcare Realty Trust Incorporated (HR) delivered a total return of +3.
4%, compared to -23. 9% for Healthpeak Properties, Inc. (DOC). Over 10 years, the gap is even starker: HR returned +42. 2% versus DOC's +9. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
03Which is safer — HR or DOC?
By beta (market sensitivity over 5 years), Healthcare Realty Trust Incorporated (HR) is the lower-risk stock at 0.
13β versus Healthpeak Properties, Inc. 's 0. 52β — meaning DOC is approximately 288% more volatile than HR relative to the S&P 500. On balance sheet safety, Healthcare Realty Trust Incorporated (HR) carries a lower debt/equity ratio of 89% versus 126% for Healthpeak Properties, Inc. — giving it more financial flexibility in a downturn.
04Which is growing faster — HR or DOC?
By revenue growth (latest reported year), Healthpeak Properties, Inc.
(DOC) is pulling ahead at 4. 5% versus -6. 9% for Healthcare Realty Trust Incorporated (HR). On earnings-per-share growth, the picture is similar: Healthcare Realty Trust Incorporated grew EPS 60. 8% year-over-year, compared to -72. 2% for Healthpeak Properties, Inc.. Over a 3-year CAGR, DOC leads at 11. 0% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
05Which has better profit margins — HR or DOC?
Healthpeak Properties, Inc.
(DOC) is the more profitable company, earning 2. 5% net margin versus -20. 8% for Healthcare Realty Trust Incorporated — meaning it keeps 2. 5% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: DOC leads at 19. 3% versus 8. 0% for HR. At the gross margin level — before operating expenses — DOC leads at 22. 5%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
06Is HR or DOC more undervalued right now?
Analyst consensus price targets imply the most upside for DOC: 8.
2% to $17. 86.
07Which pays a better dividend — HR or DOC?
All stocks in this comparison pay dividends.
Healthpeak Properties, Inc. (DOC) offers the highest yield at 7. 4%, versus 5. 6% for Healthcare Realty Trust Incorporated (HR).
08Is HR or DOC better for a retirement portfolio?
For long-horizon retirement investors, Healthcare Realty Trust Incorporated (HR) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
13), 5. 6% yield). Both have compounded well over 10 years (HR: +42. 2%, DOC: +9. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
09What are the main differences between HR and DOC?
Both stocks operate in the Real Estate sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.